VREX Stock Analysis: Buy, Sell, or Hold?
VREX - Varex Imaging Corporation Common Stock
$10.13
0.81 (8.69%)
▲
5d:
+0.6%
30d:
-15.58%
90d:
-26.33%
BUY
MODERATE Confidence
Analysis Updated: May 20, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When VREX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VREX shows positive signals but monitor for confirmation. Market pricing in 7.3% decline. Moderate conviction.
💡 BUY OPPORTUNITY: VREX shows positive signals but monitor for confirmation. Market pricing in 7.3% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.74
Based on 8.1% avg growth
INTRINSIC VALUE TODAY
$11.64
13.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VREX is currently trading at $10.13, which is considered oversold relative to its 30-day fair value range of $10.19 to $12.24. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.9) compared to its historical average (12.5). Remarkably, the market is currently pricing in an annual earnings decline of 7.3% over the next few years. This pessimistic expectation contrasts with the company's recent 453.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VREX is in a strong downtrend. Immediate support is located at $9.09, while resistance sits at $12.39. The stock is showing strong short-term momentum, up 8.7% recently.
Market Sentiment: VREX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.80 (+85.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VREX is in a strong downtrend. Immediate support is located at $9.09, while resistance sits at $12.39. The stock is showing strong short-term momentum, up 8.7% recently.
Market Sentiment: VREX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.80 (+85.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.19 -
$12.24
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.7%)
- BULLISH: Trading 85.6% below Wall St target ($18.80)
Trading Range Analysis
30-Day Trading Range
$10.19 -
$12.24
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.09
Resistance Level
$12.39
Current Trend
Strong Downtrend
Technical data as of
May 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.93
Wall Street Target
$18.80
(+85.6%)
Revenue Growth (YoY)
1.5%
Earnings Growth (YoY)
453.4%
Profit Margin
-9.6%
Valuation Discount vs History
-7.3% cheaper
PE vs Historical
9.9 vs 12.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.3%
(market-implied from PE analysis)
1-Year Target
$9.39
(-7%)
2-Year Target
$8.71
(-14%)
3-Year Target
$8.07
(-20%)
3-Yr Target (if PE normalizes)
(PE: 10→13)
$10.16
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 12.1%)
$31.67
(+213%)
Base:
(SPY PE: 9.9, Growth: 12.1%)
$14.27
(+41%)
Bear:
(PE: 8.4, Growth: 12.1%)
$12.13
(+20%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.9 to 12.5
Stabilization Target:
$12.75
(+25.9%)
PE Expansion Potential:
+25.9%
Share & Embed Analysis
Last updated: May 21, 2026 2:16 AM ET
Data refreshes hourly during market hours. Next update: 3:16 AM
Data refreshes hourly during market hours. Next update: 3:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VREX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jay K Kunkel
SELL
4510 shares
2026-03-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 67 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 57 HOLD |
